|  Help  |  About  |  Contact Us

Publication : Analysis of the proepicardium-epicardium transition during the malformation of the RXRalpha-/- epicardium.

First Author  Jenkins SJ Year  2005
Journal  Dev Dyn Volume  233
Issue  3 Pages  1091-101
PubMed ID  15861408 Mgi Jnum  J:98794
Mgi Id  MGI:3579948 Doi  10.1002/dvdy.20393
Citation  Jenkins SJ, et al. (2005) Analysis of the proepicardium-epicardium transition during the malformation of the RXRalpha(-/-) epicardium. Dev Dyn 233(3):1091-1101
abstractText  The epicardium of the heart originates from a cluster of mesothelial-derived cells that develop beneath the sinus venosus in the embryonic day (E) 9.0-9.5 mouse. The subsequent proepicardium-epicardium transition that forms the epicardial layer of epithelial cells covering the myocardial surface is nearly complete by E10.0-E10.5 and results in a fully covered heart by E11.0. In this study, we show that an established model of congenital heart disease, the retinoid X receptor alpha knockout (RXRalpha(-/-)) embryo, displays a malformed epicardium. At E10.0-E10.5, the RXRalpha(-/-) has several large regions of myocardium that remain bare. Furthermore, by E11.5-E12.5, when a complete epithelial layer is formed in the mutant, large regions of the epicardium become distended from the underlying myocardium. Close examination of the E9.5 mutant revealed an elevated apoptosis level within the proepicardial cluster of mesothelial cells. Additionally, among the extracellular matrix proteins analyzed, expression of fibronectin was elevated in the RXRalpha(-/-) as assessed by immunostaining in paraffin-embedded sections and proepicardial explants. We propose that these events contribute to a developmental delay in the formation of the epicardium, which leads to an abnormal epicardium and ultimately contributes to the cardiac malformations seen in the RXRalpha(-/-). Developmental Dynamics 233:1091-1101, 2005. (c) 2005 Wiley-Liss, Inc.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Bio Entities

Trail: Publication

0 Expression